CONFIRMED SPEAKERS AND SESSIONS

EPA is pleased to present the following experts for the below confirmed Scientific Programme sessions.

Be sure to check back regularly for added sessions.

Click here to receive updates and news about EPA 2018


Plenary Speakers

Is Schizophrenia a neurodegenerative disease?

 

Robin Murray, UK

An Innovative Conceptualisation of Mental Disorders: the Network Approach

 

Denny Borsboom, Netherlands
High risk and Resilience Studies : Lessons for Prevention, Care and ResearchMerete Nordentoft, Denmark


State of the Art Speakers

Developments in Diagnosis and Treatment of Bipolar Disorders: New Technologies and Approaches

 

Eduard Vieta, Spain
Advances in (Adolescent) Eating Disorders

Janet Treasure, UK
Youth Mental Health: transition from child to adult mental health services 

Patrick McGorry, Australia
​How to address domestic and sexual violence in clinical work

​​Louise Howard, UK

Planning ahead for acute mental health crises: methods and outcomes

 

Claire Henderson, UK

Precision medicine in addiction: a bright future?

 

Wim Van den Brink, Netherlands


Debate Speakers

Antipsychotic treatment: polypharmacy is better than monotherapy - PRO

 

Christopher Correll, USA

Antipsychotic treatment: polypharmacy is better than monotherapy - CON

 

Stefan Leucht, Germany
Assisted suicide in psychiatric patients - PROJoris Vandenberghe, Belgium

​Assisted suicide in psychiatric patients - CONPhilippe Courtet, France

Disclosing a mental disorder: do the advantages outweigh the disadvantages? - PRO

​Sara Evans Lacko, UK
​Disclosing a mental disorder: do the advantages outweigh the disadvantages? - CON

Wilma Boevink, Netherlands

Symposia Speakers

Symposia TitleLecture TitleSpeaker
Brain mechanisms of resilience to mood and psychotic disordersIdentifying the brain mechanisms of resilience to stressful life events, psychological distress and depression​Andrew McIntosh, UK
​Identifying the brain mechanisms of resilience to familial risk for bipolar disorder​Sophia Frangou, USA
​Brain volume abnormalities in different types of first degree relatives of schizophrenia and bipolar disorder: an ENIGMA study​Neeltje Van Haren, Netherlands
​Polygenic risk profile score increases schizophrenia liability mostly through cognition pathways: Mathematical causation models with latent cognition and polygenic risk​Timothea Toulopoulou, Turkey
Setting priorities for mental health research in Europe​The ROAMER project: a roadmap for mental health research in Europe​Josep Maria Haro, Spain
​Priorities for mental health research in Europe: A survey among national stakeholders' associations within the ROAMER project​Andrea Fiorillo, Italy
​Defining research priorities for mental health: an integrated and comprehensive ROADMAP​Til Wykes, UK
​The psychological perspective on mental health and mental disorder research in Europe​Ulrich Wittchen, Germany
Revision of the International Classification of Diseases – State of the art in ICD-11 Field Studies​Results from recent ICD-11 Field Studies in Germany ​Wolfgang Gaebel, Germany
​Current developments in overall ICD-revision on mental, behavioural or neurodevelopmental disorders​Geoffrey Reed, Switzerland
​Personality disorders in ICD-11 - current statusSabine Herpertz, Germany
​ICD- 11 and the future of disease classification in psychiatry​Mario Maj, Italy
Forcibly displaced people and mental health in Europe: challenges and needsDimensions of the problem and the psychosocial context Levent Küey, Turkey
 Traumas faced on the wayIris Tatjana Graef-Calliess, Germany
 Mental health consequencesMeryam Schouler-Oçak, Germany
 Mental health services for asylum seekers and refugeesMarianne Carisius Kastrup, Denmark
ADHD and Addiction, towards a consensusEpidemiology of ADHD and SUDMassimo Clerici, Italy
 Concept of Comorbidity on ADHD and SUDWim Van den Brink, Netherlands
 International Statement on ADHD in patients with SUDCleo Crunelle, Belgium
 Treatment of ADHD in patients with SUDs: new evidences

Friead Matthys, Belgium